Monoclonal antibodies that specifically bind to ANGPTL4 are provided.
Monoclonal antibodies that neutralize at least one activity of ANGPTL4
are provided. Methods of treating a disorder of lipid metabolism using
neutralizing monoclonal antibodies are provided.